Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 5 of 5 entries
Sorted by: Best Match Show Resources per page
Hydrogenation of carbon dioxide to methanol using a homogeneous ruthenium-Triphos catalyst: from mechanistic investigations to multiphase catalysis.

Chemical science

Wesselbaum S, Moha V, Meuresch M, Brosinski S, Thenert KM, Kothe J, Stein TV, Englert U, Hölscher M, Klankermayer J, Leitner W.
PMID: 30154993
Chem Sci. 2015 Jan 01;6(1):693-704. doi: 10.1039/c4sc02087a. Epub 2014 Aug 27.

The hydrogenation of CO

Cite
Wesselbaum S, Moha V, Meuresch M, et al. Hydrogenation of carbon dioxide to methanol using a homogeneous ruthenium-Triphos catalyst: from mechanistic investigations to multiphase catalysis. Chem Sci. 2014;6(1):693-704doi: 10.1039/c4sc02087a.
Wesselbaum, S., Moha, V., Meuresch, M., Brosinski, S., Thenert, K. M., Kothe, J., Stein, T. V., Englert, U., Hölscher, M., Klankermayer, J., & Leitner, W. (2015). Hydrogenation of carbon dioxide to methanol using a homogeneous ruthenium-Triphos catalyst: from mechanistic investigations to multiphase catalysis. Chemical science, 6(1), 693-704. https://doi.org/10.1039/c4sc02087a
Wesselbaum, Sebastian, et al. "Hydrogenation of carbon dioxide to methanol using a homogeneous ruthenium-Triphos catalyst: from mechanistic investigations to multiphase catalysis." Chemical science vol. 6,1 (2015): 693-704. doi: https://doi.org/10.1039/c4sc02087a
Wesselbaum S, Moha V, Meuresch M, Brosinski S, Thenert KM, Kothe J, Stein TV, Englert U, Hölscher M, Klankermayer J, Leitner W. Hydrogenation of carbon dioxide to methanol using a homogeneous ruthenium-Triphos catalyst: from mechanistic investigations to multiphase catalysis. Chem Sci. 2015 Jan 01;6(1):693-704. doi: 10.1039/c4sc02087a. Epub 2014 Aug 27. PMID: 30154993; PMCID: PMC6085670.
Copy Download .nbib Format: NLM
Risk factors for nosocomial SARS-CoV-2 infections in patients: results from a retrospective matched case-control study in a tertiary care university center.

Antimicrobial resistance and infection control

Aghdassi SJS, Schwab F, Peña Diaz LA, Brodzinski A, Fucini GB, Hansen S, Kohlmorgen B, Piening B, Schlosser B, Schneider S, Weikert B, Wiese-Posselt M, Wolff S, Behnke M, Gastmeier P, Geffers C.
PMID: 35039089
Antimicrob Resist Infect Control. 2022 Jan 17;11(1):9. doi: 10.1186/s13756-022-01056-4.

BACKGROUND: Factors contributing to the spread of SARS-CoV-2 outside the acute care hospital setting have been described in detail. However, data concerning risk factors for nosocomial SARS-CoV-2 infections in hospitalized patients remain scarce. To close this research gap and...

Cite
Aghdassi SJS, Schwab F, Peña Diaz LA, et al. Risk factors for nosocomial SARS-CoV-2 infections in patients: results from a retrospective matched case-control study in a tertiary care university center. Antimicrob Resist Infect Control. 2022;11(1):9doi: 10.1186/s13756-022-01056-4.
Aghdassi, S. J. S., Schwab, F., Peña Diaz, L. A., Brodzinski, A., Fucini, G. B., Hansen, S., Kohlmorgen, B., Piening, B., Schlosser, B., Schneider, S., Weikert, B., Wiese-Posselt, M., Wolff, S., Behnke, M., Gastmeier, P., & Geffers, C. (2022). Risk factors for nosocomial SARS-CoV-2 infections in patients: results from a retrospective matched case-control study in a tertiary care university center. Antimicrobial resistance and infection control, 11(1), 9. https://doi.org/10.1186/s13756-022-01056-4
Aghdassi, Seven Johannes Sam, et al. "Risk factors for nosocomial SARS-CoV-2 infections in patients: results from a retrospective matched case-control study in a tertiary care university center." Antimicrobial resistance and infection control vol. 11,1 (2022): 9. doi: https://doi.org/10.1186/s13756-022-01056-4
Aghdassi SJS, Schwab F, Peña Diaz LA, Brodzinski A, Fucini GB, Hansen S, Kohlmorgen B, Piening B, Schlosser B, Schneider S, Weikert B, Wiese-Posselt M, Wolff S, Behnke M, Gastmeier P, Geffers C. Risk factors for nosocomial SARS-CoV-2 infections in patients: results from a retrospective matched case-control study in a tertiary care university center. Antimicrob Resist Infect Control. 2022 Jan 17;11(1):9. doi: 10.1186/s13756-022-01056-4. PMID: 35039089.
Copy Download .nbib Format: NLM
Synergistic effects within a C2-symmetric organocatalyst: the potential formation of a chiral catalytic pocket.

Organic & biomolecular chemistry

Delaney JP, Brozinski HL, Henderson LC.
PMID: 23455677
Org Biomol Chem. 2013 May 14;11(18):2951-60. doi: 10.1039/c3ob27250h.

This study describes the synthesis of five novel C2-symmetric organocatalysts that facilitate the on-water asymmetric aldol reaction at low catalyst loading (1 mol%) without the use of additives. Each catalyst is composed of two diprolinamide units joined by a...

Cite
Delaney JP, Brozinski HL, Henderson LC. Synergistic effects within a C2-symmetric organocatalyst: the potential formation of a chiral catalytic pocket. Org Biomol Chem. 2013;11(18):2951-60doi: 10.1039/c3ob27250h.
Delaney, J. P., Brozinski, H. L., & Henderson, L. C. (2013). Synergistic effects within a C2-symmetric organocatalyst: the potential formation of a chiral catalytic pocket. Organic & biomolecular chemistry, 11(18), 2951-60. https://doi.org/10.1039/c3ob27250h
Delaney, Joshua P, et al. "Synergistic effects within a C2-symmetric organocatalyst: the potential formation of a chiral catalytic pocket." Organic & biomolecular chemistry vol. 11,18 (2013): 2951-60. doi: https://doi.org/10.1039/c3ob27250h
Delaney JP, Brozinski HL, Henderson LC. Synergistic effects within a C2-symmetric organocatalyst: the potential formation of a chiral catalytic pocket. Org Biomol Chem. 2013 May 14;11(18):2951-60. doi: 10.1039/c3ob27250h. PMID: 23455677.
Copy Download .nbib Format: NLM
Production, Characterization, and Use of Monoclonal Antibodies Against gp51 Protein to Diagnose Bovine Leukemia Virus Infection.

BioResearch open access

Troiano LD, Thomaz-Soccol V, Agottani JV, Brodzinski J, Penha TR, Ozaki SC.
PMID: 23515423
Biores Open Access. 2013 Feb;2(1):55-60. doi: 10.1089/biores.2012.0295.

Enzootic bovine leukosis (EBL) is a retroviral infection that causes persistent lymphocytosis and lymphosarcoma in cattle. The economic importance of infection by bovine leukemia virus (BLV) is due to several factors, including losses in exportation, treatment of secondary infection,...

Cite
Troiano LD, Thomaz-Soccol V, Agottani JV, et al. Production, Characterization, and Use of Monoclonal Antibodies Against gp51 Protein to Diagnose Bovine Leukemia Virus Infection. Biores Open Access. 2013;2(1):55-60doi: 10.1089/biores.2012.0295.
Troiano, L. D., Thomaz-Soccol, V., Agottani, J. V., Brodzinski, J., Penha, T. R., & Ozaki, S. C. (2013). Production, Characterization, and Use of Monoclonal Antibodies Against gp51 Protein to Diagnose Bovine Leukemia Virus Infection. BioResearch open access, 2(1), 55-60. https://doi.org/10.1089/biores.2012.0295
Troiano, Ludmilla D C, et al. "Production, Characterization, and Use of Monoclonal Antibodies Against gp51 Protein to Diagnose Bovine Leukemia Virus Infection." BioResearch open access vol. 2,1 (2013): 55-60. doi: https://doi.org/10.1089/biores.2012.0295
Troiano LD, Thomaz-Soccol V, Agottani JV, Brodzinski J, Penha TR, Ozaki SC. Production, Characterization, and Use of Monoclonal Antibodies Against gp51 Protein to Diagnose Bovine Leukemia Virus Infection. Biores Open Access. 2013 Feb;2(1):55-60. doi: 10.1089/biores.2012.0295. PMID: 23515423; PMCID: PMC3569942.
Copy Download .nbib Format: NLM
[Hepatitis B virus infection and vaccine-induced immunity: the role of sociodemographic determinants : Results of the study "German Health Interview and Examination Survey for Adults" (DEGS1, 2008-2011)].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz

Brodzinski A, Neumeyer-Gromen A, Dudareva S, Zimmermann R, Latza U, Bremer V, Poethko-Müller C.
PMID: 34958395
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2021 Dec 27; doi: 10.1007/s00103-021-03473-z. Epub 2021 Dec 27.

BACKGROUND AND OBJECTIVE: Even though the prevalence of hepatitis B virus (HBV) infection in Germany is low, it is important to identify vulnerable groups and targeted approaches for infection prevention. Previous analyses from the "German Health Interview and Examination...

Cite
Brodzinski A, Neumeyer-Gromen A, Dudareva S, et al. Hepatitis-B-Virus-Infektionen und impfinduzierte Immunität: die Rolle von soziodemografischen Determinanten : Ergebnisse der „Studie zur Gesundheit Erwachsener in Deutschland“ (DEGS1, 2008–2011). [Hepatitis B virus infection and vaccine-induced immunity: the role of sociodemographic determinants : Results of the study "German Health Interview and Examination Survey for Adults" (DEGS1, 2008-2011)]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2021;doi: 10.1007/s00103-021-03473-z.
Brodzinski, A., Neumeyer-Gromen, A., Dudareva, S., Zimmermann, R., Latza, U., Bremer, V., & Poethko-Müller, C. (2021). Hepatitis-B-Virus-Infektionen und impfinduzierte Immunität: die Rolle von soziodemografischen Determinanten : Ergebnisse der „Studie zur Gesundheit Erwachsener in Deutschland“ (DEGS1, 2008–2011). [Hepatitis B virus infection and vaccine-induced immunity: the role of sociodemographic determinants : Results of the study "German Health Interview and Examination Survey for Adults" (DEGS1, 2008-2011)]. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, . https://doi.org/10.1007/s00103-021-03473-z
Brodzinski, Annika, et al. "Hepatitis-B-Virus-Infektionen und impfinduzierte Immunität: die Rolle von soziodemografischen Determinanten : Ergebnisse der „Studie zur Gesundheit Erwachsener in Deutschland“ (DEGS1, 2008–2011)." [Hepatitis B virus infection and vaccine-induced immunity: the role of sociodemographic determinants : Results of the study "German Health Interview and Examination Survey for Adults" (DEGS1, 2008-2011)]. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz vol. (2021). doi: https://doi.org/10.1007/s00103-021-03473-z
Brodzinski A, Neumeyer-Gromen A, Dudareva S, Zimmermann R, Latza U, Bremer V, Poethko-Müller C. Hepatitis-B-Virus-Infektionen und impfinduzierte Immunität: die Rolle von soziodemografischen Determinanten : Ergebnisse der „Studie zur Gesundheit Erwachsener in Deutschland“ (DEGS1, 2008–2011). [Hepatitis B virus infection and vaccine-induced immunity: the role of sociodemographic determinants : Results of the study "German Health Interview and Examination Survey for Adults" (DEGS1, 2008-2011)]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2021 Dec 27; doi: 10.1007/s00103-021-03473-z. Epub 2021 Dec 27. German. PMID: 34958395.
Copy Download .nbib Format: NLM
Showing 1 to 5 of 5 entries